Journals 2020
Control of Synthetic Feasibility of Compounds Generated with CReM. Journal of chemical information and modeling. 2020, 60(12), 6074-6080, ISSN: 1549-9596, PMID: 33167612,
JURIKOVA, T., D. LUPTAKOVA, O. KOFRONOVA, A. SKRIBA, J. NOVAK, H. MARESOVA, A. PALYZOVA, M. PETŘÍK, V. HAVLÍČEK, O. BENADA
KIEŁCZEWSKA, U., R. JORDA, G. GONZALES, J. MORZYCKI, H. AJANI, K. SVRCKOVA, S. STEPANKOVA, A. WOJTKIELEWICZ
The synthesis and cholinesterase inhibitory activities of solasodine analogues with seven-membered F ring. The Journal of Steroid Biochemistry and Molecular Biology. 2020, 205, 105776, ISSN: 0960-0760, PMID: 33130020,
SCHADICH, E., A. KRYSHCHYSHYN-DYLEVYCH, S. HOLOTA, P. POLISHCHUK, P. DŽUBÁK, S. GURSKÁ, M. HAJDÚCH, R. LESYK
Assessing different thiazolidine and thiazole based compounds as antileishmanial scaffolds. Bioorganic & Medicinal Chemistry Letters. 2020, 30(23), 127616, ISSN: 0960-894X, PMID: 33091607,
Small Natural and Synthetic Molecules for Therapeutic Use. Current Pharmaceutical Design. 2020, 26(35), 4349-4350, ISSN: 1381-6128, PMID: 33081655,
KARASKOVA, E., D. POSPÍŠILOVÁ, M. VELGANOVA-VEGHOVA, M. GERYK, J. VOLEJNÍKOVÁ, D. HOLUB, M. HAJDÚCH
Importance of Hepcidin in the Etiopathogenesis of Anemia in Inflammatory Bowel Disease. Digestive Diseases and Sciences. 2020, 66(10), 3263-3269, ISSN: 0163-2116, PMID: 33063192,
TINKOV, O., P. POLISHCHUK, M. MATVEIEVA, V. GRIGOREV, L. GRIGOREVA, Y. POROZOV
The Influence of Structural Patterns on Acute Aquatic Toxicity of Organic Compounds. Molecular Informatics. 2020, 40(9), e2000209, ISSN: 1868-1743, PMID: 33029954,
RUČILOVÁ, V., A. SWIERRCZEK, D. VANDA, P. FUNK, B. LEMROVÁ, A. GAWALSKA, A. BUCKI, B. NOWAK, M. ZADROZNA, K. POCIECHA, M. SOURAL, E. WYSKA, M. PAWLOWSKI, G. CHLON-RZEPA, P. ZAJDEL
New imidazopyridines with phosphodiesterase 4 and 7 inhibitory activity and their efficacy in animal models of inflammatory and autoimmune diseases. European Journal of Medicinal Chemistry. 2020, 209, 112854, ISSN: 0223-5234, PMID: 33022582,
SPISAROVÁ, M., B. MELICHAR, D. VITÁSKOVÁ, H. ŠTUDENTOVÁ
Pembrolizumab plus axitinib combination and the paradigm change in the treatment of advanced renal cell carcinoma. Future Oncology. 2020, 17(3), 241-254, ISSN: 1479-6694, PMID: 33016119,